Brief: Recursion Pharmaceuticals Inc Files For Class A Common Stock Offering Of Up To $200 Million - SEC Filing
26/06/2024 21:04
Recursion Pharmaceuticals Inc RXRX.O :
* RECURSION PHARMACEUTICALS INC FILES FOR CLASS A COMMON
STOCK
OFFERING OF UP TO $200 MILLION - SEC FILING
Source text for Eikon: ID:n0001601830-24-000088
Further company coverage: RXRX.O
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million